Abstract. Lipoprotein glomerulopathy (LPG) is a unique renal disease characterized by intraglomerular lipoprotein thrombi associated with severe proteinuria and frequent progression to renal failure. The histologic hallmark of LPG is the presence of laminated thrombi, consisting of lipid droplet, within the lumina of dilated glomerular capillaries. The findings of thrombi consisting of lipoproteins raised the possibilities that LPG might be related to a primary abnormality in lipid metabolism. However, the precise pathogenic basis of LPG remains unresolved. It was herein found that chronic graft-versus-host disease (GVHD) induced by the transfer of Ia-incompatible spleen cells from B6.C-H2 bm12 into coisogenic C57BL/6 mice with deficiency of Fc receptor ␥ chain (FcR␥) resulted in glomerulopathy that resembled LPG. The uptake of acetylated LDL was partially decreased in peritoneal macrophages isolated from FcR␥-deficient mice compared with wild-type mice, suggesting that partial impairment of modified LDL uptake might contribute to the development of LPG associated with chronic GVHD in FcR␥-deficient mice. LPG has been suggested to be a disorder of primary abnormality in lipid metabolism; these findings would therefore provide novel insight into the disease process.
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Lipoprotein glomerulopathy (LPG) is a unique renal disease that is characterized by intraglomerular lipoprotein thrombi associated with severe proteinuria and frequent progression to renal failure (1) . Histologically, deposition of thrombus-like substances in markedly dilated glomerular capillaries is observed, which is positively stained for Sudan III or oil red O and contains apo B and apo E. Under electron microscopy, the lipid thrombi are finely, almost concentrically lamellated, with numerous small lipid vacuoles, suggesting that they have been serially deposited within the glomerulus.
The findings of thrombi consisting of lipoproteins raised the possibilities that LPG might be related to a primary abnormality in lipid metabolism (2) . Many affected patients indeed have features of type III hyperlipidemia, characterized by elevated IDL and high apo E levels, and the glomerulopathy in Japanese patients has been shown to be associated with apo E polymorphism, especially a novel apo E variant (apo E Sendai) (3) . However, the single European LPG patient was homozygous for apo E-III, the most common phenotype in whites (4, 5) . The pathogenic basis of LPG therefore remains unresolved.
It has been shown that the transfer of allogenic T cells recognizing a difference at the MHC class II loci into nonirradiated, non-autoimmune mice leads to chronic graft-versushost disease (GVHD), which resembles the clinical feature of SLE, with similar autoantibody specificities, Ig deposition, and renal pathology (6) . We had been studying roles of Fc receptors (FcRs) in various disease processes; we therefore induced the chronic GVHD in Fc receptor ␥ chain (FcR␥)-deficient mice to determine whether FcRs contributed to the chronic autoimmune GVHD. FcRs (Fc␥RI, Fc␥RIII, and Fc⑀RI) are expressed on hematopoietic cell lineage and require a homodimer of the ␥ subunit (FcR␥) for surface expression and signal transduction in the mouse system (7), and FcR␥-deficient mice showed no expression of Fc␥RI, Fc␥RIII, and Fc⑀RI (8) .
Unexpectedly, we found that chronic GVHD induced by the transfer of spleen cells with different MHC class II into FcR␥-deficient mice resulted in glomerulopathy that resembled LPG. Our findings thus implicated FcR␥ or FcRs in the development of LPG associated with chronic GVHD.
Materials and Methods

Mice
C57BL/6 (B6) and coisogeneic B6.C-H-2bm12 (bm12) were purchased from Jackson Laboratories (Bar Harbor, ME), bred, and maintained in SPF facility of Juntendo University. FcR␥ -/-mice were generated as described previously and have C57BL/6 background (8).
Animal experiments were approved by the Institutional Review Board of Juntendo University.
Induction of Chronic GVHD
Chronic GVHD was induced as described previously (6) . Briefly, recipient mice between 2 and 4 mo of age were injected with 1 ϫ 10 8 donor splenocytes, prepared by pressing donor spleens through a wire-mesh screen into phosophate-buffered saline (PBS). The resulting single cell suspensions were washed, counted, and injected intravenously. Five mice in each group were used for the study. Blood samples were obtained from experimental mice at the induction of GVHD and at 2-wk to 4-wk intervals thereafter, and the sera were stored at Ϫ20°C for later analysis.
Evaluation of Proteinuria/Hematuria and Lipid Profiles
Urine samples (10 l) at each time point were evaluated for proteinuria and hematuria as described previously (9) . Serum samples at each time point were evaluated for the concentration of urea nitrogen, creatinine, total cholesterol, LDL, HDL, and triglyceride (TG) by standard methods.
Histology
Mice were killed at 5 mo after GVHD induction, and the kidneys were removed, fixed in 4% paraformaldehyde, embedded into paraffin, sectioned, stained with periodic acid-Schiff (PAS) solution and examined by light microscopy for histologic changes. Oil-red staining was performed by standard procedure using the renal samples without fixation.
Immunofluorescence Study
Kidney sections were stained with Rhodamin-labeled goat antimouse IgG (Cappel, Durham, NC) or rabbit anti-mouse apo E antibody (Cortex Biochem, San Leandro, CA) before incubation with FITC-labeled polyclonal goat anti-rabbit IgG (Zymed, South San Francisco, CA) as described previously (9) .
Electron Microscopy
For electron microscopy, small blocks of a specimen were fixed in 2.0% glutaraldehyde before postfixation in 1% osmim tetrooxide and embedded in Epon 812 according to the conventional methods. The samples were double stained with uranyl acetate and lead citrate.
Preparation of Peritoneal Macrophages
Mouse peritoneal macrophages were obtained as described previously (10) . Briefly, mice were injected intraperitoneally with thioglycollate broth 4 d before harvest. Mice were sacrificed, and their peritoneal cavities were rinsed with 5 ml of cold divalent cation-free phosphate-buffered saline (PD). Cells suspended in PD were washed twice by centrifugation, and resuspended in RPMI1640 (Life Technologies, Gaithersburg, MD) containing 10% fetal calf serum (FCS) at a concentration of 5 to 10 ϫ 10 6 cells/ml. The cells were then either plated on glass coverslips or kept in suspension in polypropylene tubes on ice. Recovery of thio-macrophages kept in suspension was confirmed by FACS caliber (Becton Dickinson, Mountain View, CA) with FITC-labeled Mac-3 antibody (PharMingen, San Diego, CA), and the purity was Ͼ98%. The macrophage suspensions were used for acetylated LDL uptake assay within 4 h.
Acetylated LDL Uptake
Purified acetylated-LDL labeled with the fluorescence probe, Dil (Dil-Ac-LDL) was purchased from Biomedical Technologies Inc. (Cambridge, MA). Thio-macrophages were incubated for 4 h at 37°C in the presence of Dil-Ac-LDL (10 g/ml) in RPMI 1640 Ϫ10% FCS. After the incubation, media containing Dil-Ac-LDL were removed before the cells washed 4 times with PBS. Uptake of acetylated LDL by thio-macrophages was visualized by FACS caliber, and mean fluorescence intensity was calculated using Cell Quest software (Becton Dickinson).
Statistical Analyses
Data are summarized as mean Ϯ SD. The statistical analyses of the results were performed by the amount of variance using Fisher's least significant difference test for multiple comparisons. P Ͻ 0.05 was considered to be significant.
Results
Unirradiated FcR␥-deficient mice (FcR␥ and sex-matched donor splenocytes of coisogenic B6.C-H-2 bm12 (bm12) mice to establish chronic GVHD as described previously (6) . Strain B6 and bm12 differ only in three amino acids in the ␤-chain of the I-A molecule. Anti-double stranded DNA antibody was detected in the sera of all the experimental groups to the same extent after 3 mo of GVHD induction (data not shown), confirming that chronic GVHD had been equally established in FcR␥
and FcR␥ -/-mice. Proteinuria was measured monthly in female recipients to assess renal involvement during chronic GVHD. Urine protein concentrations peaked at around 400 mg/dl in both FcR␥ ϩ/ϩ and FcR␥ -/-mice, and there was little difference between the two mouse strains in the degree of proteinuria during chronic GVHD ( Figure 1A ). There was also little difference in the degree of hematuria between FcR␥ ϩ/ϩ and FcR␥ -/-mice during chronic GVHD (Fig. 1B) . Serum urea and creatinine levels were within normal limits in FcR␥ ϩ/ϩ and FcR␥ -/-mice during the course of chronic GVHD (data not shown). In addition, serum lipid profiles of FcR␥ -/-mice were also comparable to those of FcR␥ ϩ/ϩ mice 5 mo after induction of GVHD (Table1).
Glomerular samples taken from FcR␥ ϩ/ϩ and FcR␥ -/-mice 5 mo after induction of chronic GVHD were examined histologically (Figure 2 ). Active glomerular disease was seen in FcR␥ ϩ/ϩ mice 5 mo after induction of GVHD as previously reported (6), including mesangial hypercellularity, thick capil- lary walls, and matrix expansion. Mononuclear infiltrates were also evident in the renal interstitium. In contrast, to our surprise, glomerular samples taken from FcR␥ -/-mice 5 mo after induction of chronic GVHD showed enlarged capillary lumina with pale-stained and mesh-like substances. Importantly, about 90% of the total glomeruli in the kidney section of FcR␥ -/-mice had such laminated thrombus-like substances within the lumina of dilated glomerular capillaries 5 mo after induction of GVHD. We could not find such lesions in renal samples of FcR␥ ϩ/ϩ mice 5 mo after induction of GVHD. In addition, no glomerular abnormality was observed in FcR␥ -/-mice receiving autologous (B6) splenocytes (i.e., without GVHD) 5 mo after the transfer of the cells (Figure 3A) , suggesting that the development of thrombus-like substances in the kidney of FcR␥ -/-mice was chronic GVHD-dependent. Because of the presence of thrombus-like substances in most of the glomeruli, it was difficult to see accurately whether similar nephritic lesions to FcR␥ ϩ/ϩ mice occurred in FcR␥ -/-mice after induction of GVHD. However, we found that some glomeruli (about 10% of total glomeruli) that had not developed thrombus-like lesions in FcR␥ -/-mice showed active glomerular pathology, including hypercellularity, thick capillary walls, and matrix expansion as observed in FcR␥ ϩ/ϩ mice ( Figure 3B ). In addition, mononuclear infiltrates in the renal interstitium were evident in FcR␥ -/-mice as well as in FcR␥ ϩ/ϩ mice ( Figure 2) . Furthermore, the quantity of IgG deposition in the glomerular regions was comparable between FcR␥ ϩ/ϩ and FcR␥ -/-mice ( Figure 4 ). Taken together with little difference in the severity of proteinuria and hematuria (Figure 1) , these results suggest that chronic GVHD had been equally established in FcR␥ ϩ/ϩ and FcR␥ -/-mice. The histologic findings observed in FcR␥ -/-mice 5 mo after induction of GVHD closely resembled to those of human LPG; we therefore performed specific staining for lipoproteins and electron microscopy analyses. The substances were clearly stained positive with oil-red O and with an antibody against apo E (Figure 5) . Furthermore, electron microscopy examination revealed that the thrombus-like substances had various electron densities shaped lamella structures with numerous small lipid vacuoles (Figure 6 ), suggesting that they had been serially deposited within the glomerulus. As described in the Introduction, all of these findings are characteristic features of human LPG (1). We thus concluded that chronic GVHD in FcR␥ -/-mice resulted in the development of LPG. It was shown that FcRs on macrophages were involved in the recognition and clearance of LDL (11) (12) (13) . We thus hypothesized that deficiency of FcRs on macrophages in FcR␥ -/-mice might affect uptake of modified (oxidized or acetylated) LDL at chronic inflamed kidney, resulting in lipoprotein deposition in LPG. We then compared the uptake of acetylated LDL by thioglycollate-elicited peritoneal macrophages between FcR␥ ϩ/ϩ and FcR␥ -/-mice. The uptake of acetylated LDL by activated peritoneal macrophages was partially reduced in FcR␥ -/-mice compared with macrophages purified from FcR␥ ϩ/ϩ mice ( Figure 7 ). These findings indicate that clearance of modified LDL by macrophages was partially reduced in FcR␥ -/-mice, which might be associated with the in vivo lipoprotein deposition in LPG.
Discussion
In this study, we demonstrate that chronic autoimmune GVHD in FcR␥-deficient mice resulted in the development of LPG. We and others have previously shown that an inducedmodel of immune complex-mediated glomerulonephritis or a spontaneous model of lupus nephritis in FcR␥ -/-mice resulted in reduction of the diseases (14, 15) . In either case, the development of LPG-like lesion in the kidney was not observed. Therefore, it seemed that the development of LPG was specific to chronic GVHD model in FcR␥ -/-mice. Actually, two clinical reports noted the recurrence of LPG in the transplanted kidney (4, 16, 17) . Sustained inflammation induced by chronic GVHD might thus be a predisposing factor for LPG. Macrophages possess several different receptor pathways involved in the recognition and clearance of modified (oxidized) LDL, including scavenger receptors and FcRs (18) . Regarding FcRs, the FcR subtypes, Fc␥RI and Fc␥RII, were reported to be involved in LDL uptake (11) (12) (13) . FcR␥ -/-mice failed to express Fc␥RI and Fc␥RIII, but Fc␥RII expression was retained (8) ; therefore, our findings that uptake of acetylated LDL by macrophages was partially reduced in FcR␥ -/-mice ( Figure 7 ) could be attributed to the deficiency of Fc␥RI.
Molecular mechanisms underlying the development of LPG in our experimental system requires further investigation. Our in vitro findings that uptake of acetylated LDL by macrophages was partially reduced in FcR␥ -/-mice raised one possibility that deficiency of FcRs on macrophages might affect uptake of modified (oxidized) LDL at chronic inflamed kidney, resulting in the development of LPG. It was shown that interferonv (IFN-␥) inhibited expression of scavenger receptors, whereas it enhanced expression of FcRs (19, 20) . We thus speculate that partial reduction of modified (oxidized) LDL uptake by macrophages could eventually result in the lipoprotein deposition in the kidney during the long course of chronic GVHD. Cytokines such as IFN-␥ induced by chronic GVHD might facilitate the process through favoring expression of FcRs on macrophages. In contrast, in the absence of chronic inflammation, or FcR␥ -/-mice as described in Figure 1 . Five months after the induction of GVHD, kidney sections were stained with Rhodamin-labeled anti-mouse IgG to detect Ig deposition. Equal deposition of mouse IgG located predominantly within the capillary walls was observed between FcR␥ ϩ/ϩ and FcR␥ -/-mice. scavenger receptors might be sufficient for the clearance of modified (oxidized) LDL in FcR␥ -/-mice. Mesangial cells may be also involved in the pathologic process, because expression of Fc␥RI in mesangial cells is induced by IFN-␥ (21). However, the complexity of cellular interactions between donor and host cells in GVHD system would raise several other possibilities of the mechanisms underlying the development of LPG.
It appeared that primary abnormality in lipid metabolism, such as the presence of particular apo E variants, did not contribute to the development of LPG in our system, because FcR␥ ϩ/ϩ mice that had same genetic background as FcR␥ -/-mice, except for FcR␥ chain, did not develop LPG-like lesions after induction of chronic GVHD. LPG is considered to be a heterogenous disorder (2) ; it is therefore likely that our findings reflect the pathophysiology of particular subsets of LPG, especially cases relevant to renal transplantation (5) . Genetic screening for FcR␥ or FcRs in such patients will thus be interesting for future studies.
In summary, we found that chronic autoimmune GVHD in FcR␥-deficient mice resulted in the development of LPG. LPG has been suggested to be a disorder of primary abnormality in lipid metabolism; therefore, our current findings provide novel insight into the disease process. 
